RSH 0.00% 2.9¢ respiri limited

Product tests & clinical results, facts please, page-28

  1. 466 Posts.
    lightbulb Created with Sketch. 213
    No the Company and it’s technology has evolved and progressed hugely over 10 years to now be the true leader in monitoring and management of asthma (ultimately chronic respiratory disease) with world leading technology that is now in market in Australia that can provide asthmatics for the vey first time a solution to objectively measuring their primary symptom of wheeze so as to manage their symptoms, condition and medication in real time outside the clinic / doctors office.
    That is what has been happening over the past 10 years.
 
watchlist Created with Sketch. Add RSH (ASX) to my watchlist
(20min delay)
Last
2.9¢
Change
0.000(0.00%)
Mkt cap ! $37.25M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 165814 2.7¢
 

Sellers (Offers)

Price($) Vol. No.
2.9¢ 189727 2
View Market Depth
Last trade - 16.12pm 30/08/2024 (20 minute delay) ?
RSH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.